{
  "id": "clinical#screening_cues_d76729fa",
  "content": "6C49.22 SP\n6C49.23 SF\nDiagnostic categories that apply to the various classes of psychoactive substances Diagnostic categories that apply to the various classes of psychoactive substances\n452 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nTable 6.13. contd\nEpisode Harmful pattern Substance Substance Substance\nof harmful of psychoactive dependenceb intoxication withdrawalc\npsychoactive substance usea\nsubstance use\nNicotine 6C4A.0 6C4A.10 E 6C4A.20 C 6C4A.3 6C4A.4\n6C4A.11 C 6C4A.21 EF\n6C4A.22 SP\n6C4A.23 SF\nVolatile inhalants 6C4B.0 6C4B.10 E 6C4B.20 C 6C4B.3 6C4B.4\n6C4B.11 C 6C4B.21 EF\n6C4B.22 SP\n6C4B.23 SF\nMDMA or related 6C4C.0 6C4C.10 E 6C4C.20 C 6C4C.3 6C4C.4\ndrugs, including MDA\n6C4C.11 C 6C4C.21 EF\n6C4C.22 SP\n6C4C.23 SF\nDissociative drugs, 6C4D.0 6C4D.10 E 6C4D.20 C 6C4D.3 N/A\nincluding ketamine\nand PCP 6C4D.11 C 6C4D.21 EF\n6C4D.22 SP\n6C4D.23 SF\nOther specified 6C4E.0 6C4E.10 E 6C4E.20 C 6C4E.3 6C4E.40 U\n6C4E.11 C 6C4E.21 EF 6C4E.41 PD\n6C4E.22 SP 6C4E.42 S\n6C4E.23 SF 6C4E.43 PD&S\nMultiple specified 6C4F.0 6C4F.10 E 6C4F.20 C 6C4F.3 6C4F.40 U\n6C4F.11 C 6C4F.21 EF 6C4F.41 PD\n6C4F.22 SP 6C4F.42 S\n6C4F.23 SF 6C4F.43 PD&S\nDiagnostic categories that apply to the various classes of psychoactive substances",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Screening Cues 6C49.22 SP\n6C49.23 SF\nDiagnostic categories that apply to the various classes of psychoactive substances Diagnostic categories that apply to the various classes of psychoactive substances\n452 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nTable 6.13. contd\nEpisode Harmful pattern Substance Substance Substance\nof harmful of psychoactive dependenceb intoxication withdrawalc\npsychoactive substance usea\nsubstance use\nNicotine 6C4A.0 6C4A.10 E 6C4A.20 C 6C4A.3 6C4A.4\n6C4A.11 C 6C4A.21 EF\n6C4A.22 SP\n6C4A.23 SF\nVolatile inhalants 6C4B.0 6C4B.10 E 6C4B.20 C 6C4B.3 6C4B.4\n6C4B.11 C 6C4B.21 EF\n6C4B.22 SP\n6C4B.23 SF\nMDMA or related 6C4C.0 6C4C.10 E 6C4C.20 C 6C4C.3 6C4C.4\ndrugs, including MDA\n6C4C.11 C 6C4C.21 EF\n6C4C.22 SP\n6C4C.23 SF\nDissociative drugs, 6C4D.0 6C4D.10 E 6C4D.20 C 6C4D.3 N/A\nincluding ketamine\nand PCP 6C4D.11 C 6C4D.21 EF\n6C4D.22 SP\n6C4D.23 SF\nOther specified 6C4E.0 6C4E.10 E 6C4E.20 C 6C4E.3 6C4E.40 U\n6C4E.11 C 6C4E.21 EF 6C4E.41 PD\n6C4E.22 SP 6C4E.42 S\n6C4E.23 SF 6C4E.43 PD&S\nMultiple specified 6C4F.0 6C4F.10 E 6C4F.20 C 6C4F.3 6C4F.40 U\n6C4F.11 C 6C4F.21 EF 6C4F.41 PD\n6C4F.22 SP 6C4F.42 S\n6C4F.23 SF 6C4F.43 PD&S\nDiagnostic categories that apply to the various classes of psychoactive substances 6c49.22 sp\n6c49.23 sf\ndiagnostic categories that apply to the various classes of psychoactive substances diagnostic categories that apply to the various classes of psychoactive substances\n452 clinical descriptions and di..."
}